Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jun;7(6):753-63.
doi: 10.1517/17425241003777010.

Gold nanoparticles: opportunities and challenges in nanomedicine

Rochelle Arvizo  1 , Resham Bhattacharya, Priyabrata Mukherjee
Affiliations
Review

Gold nanoparticles: opportunities and challenges in nanomedicine

Rochelle Arvizo et al. Expert Opin Drug Deliv. 2010 Jun.

Abstract

Importance of the field: Site-specific drug delivery is an important area of research that is anticipated to increase the efficacy of the drug and reduce potential side effects. Owing to this, substantial work has been done developing non-invasive and targeted tumor treatment with nanoscale metallic particles.

Areas covered in this review: This review focuses on the work done in the last few years developing gold nanoparticles as cancer therapeutics and diagnostic agents. However, there are challenges in using gold nanoparticles as drug delivery systems, such as biodistribution, pharmacokinetics and possible toxicity. Approaches to limit these issues are proposed.

What the reader will gain: Different approaches from several different disciplines are discussed. Potential clinical applications of these engineered nanoparticles are also presented.

Take home message: As a result of their unique size-dependent physicochemical and optical properties, adaptability, subcellular size and biocompatibility, these nanosized carriers offer a suitable means of transporting small molecules as well as biomacromolecules to diseased cells/tissues.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2
See this image and copyright information in PMC

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer Statistics. CA Cancer J Clin. 2009;59(4):225–249. - PubMed
    1. Stewart BW, Coates AS. Cancer Prevention: A Global Perspective. J Clin Oncol. 2005;23(2):392–403. - PubMed
    1. Edwards PP, Thomas JM. Gold in a Metallic Divided State†-†From Faraday to Present-Day Nanoscience13. Angew. Chem. Int. Ed. 2007;46(29):5480–5486. - PubMed
    1. Aaseth J, Haugen M, Forre O. Rheumatoid arthritis and metal compounds--perspectives on the role of oxygen radical detoxification. Analyst. 1998 Jan;123(1):3–6. - PubMed
    1. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 2005 Mar;5(3):161–171. - PubMed

Publication types